Screener
Thermo Fisher Scientific TMO Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 11:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000097745-26-000092
| (Dollars in millions) | Effective interest rate at March 28, 2026 | March 28, 2026 | December 31, 2025 |
|---|---|---|---|
| Other | 1 | 1 | |
| Total borrowings at par value | 43,267 | 39,459 | |
| Unamortized discount | (91) | (94) | |
| Unamortized debt issuance costs | (229) | (194) | |
| Total borrowings at carrying value | 42,947 | 39,172 | |
| Finance lease liabilities | 213 | 213 | |
| Less: Short-term obligations and current maturities | 3,090 | 3,533 | |
| Long-term obligations | $40,071 | $35,852 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Thermo Fisher Scientific's finance lease liabilities?
- Thermo Fisher Scientific (TMO) reported finance lease liabilities of $213M in Q1 2026.
- How has Thermo Fisher Scientific's finance lease liabilities changed year-over-year?
- Thermo Fisher Scientific's finance lease liabilities increased by 6.5% year-over-year, from $200M to $213M.
- What is the long-term trend for Thermo Fisher Scientific's finance lease liabilities?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's finance lease liabilities has grown at a 98.0% compound annual growth rate (CAGR), from $7M to $213M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about Thermo Fisher Scientific's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude